LEVOBUPIVACAINE ALTAN 7.5 mg/mL INJECTABLE SOLUTION AND PERFUSION SOLUTION
Ask a doctor about a prescription for LEVOBUPIVACAINE ALTAN 7.5 mg/mL INJECTABLE SOLUTION AND PERFUSION SOLUTION
How to use LEVOBUPIVACAINE ALTAN 7.5 mg/mL INJECTABLE SOLUTION AND PERFUSION SOLUTION
Introduction
Package Leaflet: Information for the User.
Levobupivacaine Altan 7.5 mg/ml Solution for Injection and Perfusion EFG
Levobupivacaine
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
|
Contents of the Package Leaflet:
- What is Levobupivacaine Altan 7.5 mg/ml and what is it used for
- What you need to know before you start using Levobupivacaine Altan 7.5 mg/ml
- How to use Levobupivacaine Altan 7.5 mg/ml
- Possible side effects
- Storage of Levobupivacaine Altan 7.5 mg/ml
- Package Contents and Additional Information
1. What is Levobupivacaine Altan 7.5 mg/ml and what is it used for
Levobupivacaine Altan 7.5 mg/ml belongs to a group of medicines called local anesthetics. This type of medicine is used to anesthetize parts of the body or to relieve pain.Adults:
Levobupivacaine Altan 7.5 mg/ml is used as a local anesthetic to anesthetize parts of the body before major surgery (except in cases of cesarean section) and minor surgery (such as in the eye or mouth).
It is also used for
- relief of pain after major surgery
Children:
Levobupivacaine Altan 7.5 mg/ml can also be used in children to anesthetize parts of the body before an operation and for pain relief after minor surgery, such as an inguinal hernia.
Levobupivacaine Altan 7.5 mg/ml has not been tested in children under 6 months.
2. What you need to know before you start using Levobupivacaine Altan 7.5 mg/ml
Do not use Levobupivacaine Altan 7.5 mg/ml
- If you are allergic (hypersensitive) to levobupivacaine, to any similar local anesthetic, or to any of the other components of this medicine (see section 6)
- If you have very low blood pressure
- To anesthetize a part of the body by injecting Levobupivacaine Altan 7.5 mg/ml intravenously. To treat pain during childbirth
Warnings and Precautions
Tell your doctor before you are given Levobupivacaine Altan 7.5 mg/ml if you have any of the following conditions or diseases. You may need closer monitoring or a lower dose.
- If you have heart problems
- If you have a nervous system disease
- If you are weak or ill
- If you are elderly
- If you have liver disease.
Using Levobupivacaine Altan 7.5 mg/ml with other medicines:
Tell your doctor or nurse if you are using, have recently used, or might use any other medicines. Tell them especially if you are taking medicines for:
- arrhythmias (such as mexiletine)
- fungal infections (such as ketoconazole) as they may affect the metabolism of Levobupivacaine Altan 7.5 mg/ml
- asthma (such as theophylline) as it may affect how long Levobupivacaine Altan 7.5 mg/ml stays in your body.
Pregnancy, Breastfeeding, and Fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or nurse before using this medicine. Levobupivacaine 7.5 mg/ml should not be administered to relieve pain during childbirth or as a local anesthetic during cesarean section. The effects of Levobupivacaine Altan 7.5 mg/ml on the fetus during the first phases of pregnancy are not known. Therefore, Levobupivacaine Altan 7.5 mg/ml should not be used during the first three months of pregnancy unless your doctor considers it necessary.
It is not known if levobupivacaine passes into breast milk. However, based on experience with similar drugs, it is expected that only small amounts of levobupivacaine will pass into breast milk.
Breastfeeding is therefore possible after using a local anesthetic.
Driving and Using Machines
Using Levobupivacaine Altan 7.5 mg/ml may have a significant effect on your ability to drive or use machines. Do not drive or use machinery until all the effects of Levobupivacaine Altan 7.5 mg/ml and surgery have passed. Make sure you are advised on this by your doctor or nurse before leaving the hospital.
Important Information about Some of the Components of Levobupivacaine Altan:
Patients on a low-sodium diet should note that this product contains 3.5 mg/ml of sodium in the solution of the bag or ampoule.
3. How to Use Levobupivacaine Altan 7.5 mg/ml
Levobupivacaine Altan 7.5 mg/ml can be injected into the parts of the body you want to anesthetize, such as the eye, arm, or leg. Your doctor and nurse will carefully monitor you while you are being given Levobupivacaine Altan 7.5 mg/ml.
Dose
The amount of Levobupivacaine Altan 7.5 mg/ml that will be given to you and how often it will be given will depend on what it is used for and your physical condition, age, and weight. You will be given the minimum dose that achieves anesthesia in the required area. The dose will be carefully chosen by your doctor.
If you are given more Levobupivacaine Altan 7.5 mg/ml than you should
If you are given more Levobupivacaine Altan 7.5 mg/ml than you should, you may experience numbness of the tongue, dizziness, blurred vision, muscle contraction, severe breathing difficulties (including respiratory arrest), and even convulsions. If you notice any of these symptoms, tell your doctor immediately.
Sometimes too much Levobupivacaine Altan 7.5 mg/ml can also cause low blood pressure, bradycardia, or tachycardia, and changes in your heart rhythm. Your doctor may need to give you other medicines to help stop these symptoms.
If you have any further questions about the use of this medicine, ask your doctor or nurse.
4. Possible Side Effects
Like all medicines, Levobupivacaine Altan 7.5 mg/ml can cause side effects, although not everybody gets them. Some of the side effects of Levobupivacaine Altan 7.5 mg/ml can be serious.
If you think you are experiencing any of the side effects listed below, tell your doctor or nurse immediately.
Very Common Side Effects (may affect more than 1 in 10 people):
- feeling of tiredness or weakness, difficulty breathing, paleness (these are all signs of anemia)
- low blood pressure
- nausea
Common Side Effects (may affect up to 1 in 10 people):
- dizziness
- headache
- vomiting
- fetal distress
- back pain
- fever
- postoperative pain
Frequency Not Known (frequency cannot be estimated from available data):
- serious allergic reactions (hypersensitivity) that cause severe difficulty breathing, difficulty swallowing, hives, and very low blood pressure.
- allergic reactions (hypersensitivity) recognizable by having red and irritated skin, sneezing, excessive sweating, increased heart rate, fainting, or swelling of the face, lips, mouth, tongue, or throat
- convulsions
- loss of consciousness
- drowsiness
- blurred vision
- respiratory arrest
- heart block or cardiac arrest
- localized tingling
- numb tongue
- muscle weakness or tremors
- loss of control of urine and feces
- paralysis
- tingling, numbness, or other unusual sensation
- prolonged erection of the penis, which can be painful
- nerve disorders that can include drooping eyelids, small pupils (black center of the eye), sunken eye socket, sweating, and/or redness of one side of the face.
Bradycardia, tachycardia, irregular heartbeat, and changes in heart rhythm that can be seen on an ECG (electrocardiogram) have also been reported as side effects.
In very rare cases, some side effects can last for a long time or become permanent.
Reporting Side Effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storage of Levobupivacaine Altan 7.5 mg/ml
No special storage conditions are required.
Keep out of sight and reach of children.
Do not use Levobupivacaine Altan 7.5 mg/ml after the expiration date stated on the packaging after EXP. The expiration date is the last day of the month indicated.
Your doctor will keep this medicine for you.
The solution should be used immediately after opening.
Do not use Levobupivacaine Altan 7.5 mg/ml if you notice particles in the solution.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
6. Package Contents and Additional Information
Composition of Levobupivacaine Altan 7.5 mg/ml
The active substance is levobupivacaine (as hydrochloride)
One milliliter of solution contains 7.5 mg of levobupivacaine (as hydrochloride). Each 10 ml ampoule contains 75 mg.
The other ingredients are water for injections, sodium chloride, sodium hydroxide, and hydrochloric acid.
Appearance of the Product and Package Contents
It is a clear, transparent solution packaged in Type I glass ampoules.
Each ampoule contains 75 mg of levobupivacaine in a 10 ml ampoule. It is supplied in packs of 5 and 10 ampoules.
Marketing Authorization Holder and Manufacturer:
Marketing Authorization Holder:
Altan Pharmaceuticals, S.A.
C/ Cólquide, Nº 6, Portal 2, 1ª Planta, Oficina F. Edificio Prisma,
28230 Las Rozas (Madrid) – Spain
Manufacturer:
Altan Pharmaceuticals, S.A.
Avda. de la Constitución, 198-199, Polígono Industrial Monte Boyal,
Casarrubios del Monte, 45950 Toledo – Spain
Altan Pharmaceuticals, S.A.
Polígono Industrial de Bernedo s/n
01118 Bernedo Álava-España
OTHER PRESENTATIONSLevobupivacaine Altan 2.5 mg/ml Solution for Injection and Perfusion EFGLevobupivacaine Altan 5 mg/ml Solution for Injection and Perfusion EFGLevobupivacaine Altan 1.25 mg/ml Solution for Perfusion EFGLevobupivacaine Altan 0.625 mg/ml Solution for Perfusion EFG
Date of Last Revision of this Leaflet:07/2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)http://www.aemps.gob.es
-----------------------------------------------------------------------------------------------------------------------
This information is intended only for healthcare professionals:
Instructions for Use/Handling
Levobupivacaine Altan 7.5 mg/ml is for single use only. Discard any unused solution.
From a microbiological point of view, the product should be used immediately after opening. If not, the storage time and conditions of the product before use are the responsibility of the user.
Experience with the safety of levobupivacaine treatment for more than 24 hours is limited.
Expiration after first opening: The product must be used immediately
Expiration after dilution with a 0.9% sodium chloride solution: The chemical and physical stability in use has been demonstrated in 0.9% sodium chloride solutions for 7 days at 20-22°C. As with all parenteral medicines, the solution/dilution should be visually inspected before use. Only clear solutions without visible particles should be used.
Dilutions of standard levobupivacaine solutions should be performed with sodium chloride 9 mg/ml (0.9%) injectable solution and using aseptic techniques.
It has been shown that 8.4 micrograms/ml of clonidine, 0.05 mg/ml of morphine, and 4 micrograms/ml of fentanyl are compatible with levobupivacaine in 0.9% sodium chloride injectable solution. The chemical and physical stability in use has been demonstrated with clonidine, morphine, or fentanyl for 40 hours at 20-22°C.
Levobupivacaine Altan 7.5 mg/ml should not be mixed with other medicines except those listed above. Dissolution with alkaline solutions such as sodium bicarbonate may cause precipitation.
Method of Administration
Administration of Levobupivacaine should be performed by a doctor who has the necessary training and experience or under their supervision.
For information on posology, consult the Product Characteristics.
Careful aspiration should be performed before and during injection to prevent intravascular injection.
Aspiration should be repeated before and during the administration of a bolus dose, which should be injected slowly and in increments of 7.5 - 30 mg/min, while monitoring the patient's vital functions and maintaining verbal contact with them.
If toxic symptoms appear, the injection should be stopped immediately.
- Country of registration
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to LEVOBUPIVACAINE ALTAN 7.5 mg/mL INJECTABLE SOLUTION AND PERFUSION SOLUTIONDosage form: INJECTABLE PERFUSION, 0.625 mg/mLActive substance: levobupivacaineManufacturer: Altan Pharmaceuticals SaPrescription requiredDosage form: INJECTABLE PERFUSION, 1.25 mg/mlActive substance: levobupivacaineManufacturer: Altan Pharmaceuticals SaPrescription requiredDosage form: INJECTABLE, 5 mg/mlActive substance: levobupivacaineManufacturer: Altan Pharmaceuticals SaPrescription required
Alternatives to LEVOBUPIVACAINE ALTAN 7.5 mg/mL INJECTABLE SOLUTION AND PERFUSION SOLUTION in other countries
The best alternatives with the same active ingredient and therapeutic effect.
Alternative to LEVOBUPIVACAINE ALTAN 7.5 mg/mL INJECTABLE SOLUTION AND PERFUSION SOLUTION in Poland
Online doctors for LEVOBUPIVACAINE ALTAN 7.5 mg/mL INJECTABLE SOLUTION AND PERFUSION SOLUTION
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for LEVOBUPIVACAINE ALTAN 7.5 mg/mL INJECTABLE SOLUTION AND PERFUSION SOLUTION – subject to medical assessment and local rules.
Get updates and exclusive offers
Be the first to know about new services, marketplace updates, and subscriber-only promos.
